Pharm.D

RAK Medical and Health Sciences University ,Ras Al Khaimah, United Arab Emirates (UAE), has been established by the Ras Al Khaimah Human Development Foundation (RAK–HDF) under the visionary leadership of His Highness Sheikh Saud Bin Saqr Al Qasimi, Supreme Council Member & Ruler of Ras Al Khaimah and Chancellor of the University.

This time people performed well. looks like approved than previous tests. Passing marks was 40 % and so many of the candidates reach there to pass. Let me remind you there was no negative marks system otherwise it can affect your result. But anyways overall it was nice performance.

That was real traffic of candidates on GPAT-TUTOR Platform for OCF 2011's test-2. The no. of candidates participating in OCF competition is increased for TEST-2. The test was much easier than test -1 and passing percentage was 50 % ... But Let me tell you very few of you cross that margin. But don’t worry as in GPAT if you would score atleast 35-40 %, you can qualify the pharma giant entrance.

Celestial Biolabs Ltd is an ISO 9001-2001 certified listed company with NSE and BSE company ,Celestial has been providing customized IT solutions for Pharma, Bio-pharma, Biotech and manufacturing, Now Expanding business in Pharma Exports.

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

Students from around 190 different colleges of India were registered for first test of OCF - 2011. And average result was poor for this test... Many of the participants failed to cross even 50 % marks. But no need to worry Test - 2 is waiting for you all. It will be on 21^st August, 2011

In an urge to provide quality pharma education online, PharmaTutor.org has decided to conduct an online competition focusing various pharma entrance exams such as GPAT, NIPER-JEE, CET, MAHE, Bits-exam, NMAT and others.

GPAT-2011 PAPER

{Answers are on the end page of question Paper}